14-41886641-T-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_152447.5(LRFN5):āc.16T>Cā(p.Phe6Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000215 in 1,580,012 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_152447.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LRFN5 | NM_152447.5 | c.16T>C | p.Phe6Leu | missense_variant | 3/6 | ENST00000298119.9 | NP_689660.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LRFN5 | ENST00000298119.9 | c.16T>C | p.Phe6Leu | missense_variant | 3/6 | 1 | NM_152447.5 | ENSP00000298119 | P3 | |
LRFN5 | ENST00000554171.1 | c.16T>C | p.Phe6Leu | missense_variant | 5/7 | 1 | ENSP00000451067 | A1 | ||
LRFN5 | ENST00000554120.5 | c.16T>C | p.Phe6Leu | missense_variant | 3/4 | 5 | ENSP00000451897 | A1 |
Frequencies
GnomAD3 genomes AF: 0.000210 AC: 32AN: 152214Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000189 AC: 42AN: 221742Hom.: 0 AF XY: 0.000167 AC XY: 20AN XY: 120100
GnomAD4 exome AF: 0.000215 AC: 307AN: 1427680Hom.: 0 Cov.: 33 AF XY: 0.000212 AC XY: 150AN XY: 708598
GnomAD4 genome AF: 0.000210 AC: 32AN: 152332Hom.: 0 Cov.: 32 AF XY: 0.000175 AC XY: 13AN XY: 74486
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 12, 2021 | The c.16T>C (p.F6L) alteration is located in exon 3 (coding exon 1) of the LRFN5 gene. This alteration results from a T to C substitution at nucleotide position 16, causing the phenylalanine (F) at amino acid position 6 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at